FNDC5 and Hypertension: Ye et al. found that up-regulating fibronectin type III domain containing 5 (FNDC5) via miR-135a-5p inhibition substantially weakens the proliferation and vascular remodeling of VSMCs and alleviates hypertension in spontaneously hypertensive rats (Ye et al., 2021).